Berard E, Iordache A, Barrillon D, Bayle J
Department of Nephrology, University Hospital of Nice, France.
Int J Clin Pharmacol Res. 1995;15(3):127-33.
Although carnitine levels and carnitine therapy have been extensively studied in dialysis patients, the pathophysiology of L-carnitine is poorly understood. The usual therapeutic dose is 20-30 mg/kg, resulting in dramatic increases of circulating levels above the normal values. Guided by studies on its lipidic effect and by our experience of its action on haematocrit, we propose the use of 2-3 mg/kg of L-carnitine in future prospective studies.
尽管已对透析患者的肉碱水平和肉碱治疗进行了广泛研究,但左旋肉碱的病理生理学仍知之甚少。通常的治疗剂量为20-30mg/kg,会使循环水平大幅升高至正常值以上。基于对其脂质效应的研究以及我们对其对血细胞比容作用的经验,我们建议在未来的前瞻性研究中使用2-3mg/kg的左旋肉碱。